Format

Send to

Choose Destination
See comment in PubMed Commons below
Lancet. 1999 Nov 13;354(9191):1698-9.

Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.

Abstract

Three patients with diffuse large B-cell type of post-transplant lymphoproliferative disease after lung transplantation were treated with rituximab, an anti-CD20 monoclonal antibody. Treatment resulted in two complete remissions and one non-response.

PMID:
10568575
DOI:
10.1016/S0140-6736(99)02058-9
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center